In situ study on the pathogenesis and immune reaction of equine herpesvirus type 1 (EHV‐1) infections in mice

The mouse model was used to study the pathogenesis of equine herpesvirus type 1 (EHV‐1) after primary and secondary intranasal infections. Within a few hours after infection, EHV‐1 was found in nasal and olfactorial epithelium and sub‐epithelial cells of the respiratory mucosa, but antigen‐specific immune cells were never detected. Next to the lung, EHV‐1 was transmitted early and directly to the brain, both via the olfactory route and the trigeminal nerve, but traces of degenerative or inflammatory processes were not detected there. In the lung, the immune cells residing or invading the parenchyma did not contain viral DNA or proteins. The primary immune response in the lungs was an alveolar and interstitial inflammation, dominated by the sequential appearance of neutrophils and macrophages, while the number of T and B lymphocytes remained unaltered. Within 24 hr after re‐infection, lymphocytes accumulated around the blood vessels, outnumbering monocytes more than twofold, without neutrophils appearing. The lymphocytes comprised of little more B than T cells and the T cells were predominantly CD8+ cells. Those and B cells infiltrated the parenchyma. These results show the route of virus distribution and demonstrate the lack of antigen‐specific immune cells in the lungs of mice after primary intranasal infection with EHV‐1.

[1]  J. Kydd,et al.  Residence and recruitment of leucocytes to the equine lung after EHV-1 infection. , 1996, Veterinary immunology and immunopathology.

[2]  H. Field,et al.  Molecular studies of the acute infection, latency and reactivation of equine herpesvirus-1 (EHV-1) in the mouse model. , 1996, Virus research.

[3]  R. A. Killington,et al.  Role of T-cells, virus neutralising antibodies and complement-mediated antibody lysis in the immune response against equine herpesvirus type-1 (EHV-1) infection of C3H (H-2k) and BALB/c (H-2d) mice. , 1995, Research in veterinary science.

[4]  H. Nauwynck,et al.  Dissemination of wild-type and gC-, gE-and gI-deleted mutants of Aujeszky's disease virus in the maxillary nerve and trigeminal ganglion of pigs after intranasal inoculation. , 1995, The Journal of general virology.

[5]  B. Crabb,et al.  Equine herpesviruses 4 (equine rhinopneumonitis virus) and 1 (equine abortion virus). , 1995, Advances in virus research.

[6]  J. Kydd,et al.  Distribution of equid herpesvirus-1 (EHV-1) in respiratory tract associated lymphoid tissue: implications for cellular immunity. , 1994, Equine veterinary journal.

[7]  M. Pensaert,et al.  Role of envelope glycoproteins gI, gp63 and gIII in the invasion and spread of Aujeszky's disease virus in the olfactory nervous pathway of the pig. , 1994, The Journal of general virology.

[8]  H. Field,et al.  The trigeminal ganglion is a location for equine herpesvirus 1 latency and reactivation in the horse. , 1994, The Journal of general virology.

[9]  J. Slater,et al.  A nested PCR for the detection and differentiation of EHV-1 and EHV-4. , 1993, Journal of virological methods.

[10]  H. Iwai,et al.  Equid herpesvirus 1 infection in mice. , 1993, The Journal of veterinary medical science.

[11]  E. Telford,et al.  The DNA sequence of equine herpesvirus-1. , 1992, Virology.

[12]  L. Griffiths,et al.  Latent equid herpesviruses 1 and 4: detection and distinction using the polymerase chain reaction and co-cultivation from lymphoid tissues. , 1992, The Journal of general virology.

[13]  J. Biewenga,et al.  The role of nasopharyngeal lymphoid tissue. , 1992, Immunology today.

[14]  A. Awan,et al.  The pathogenesis of equine herpesvirus type 1 in the mouse: a new model for studying host responses to the infection. , 1990, The Journal of general virology.

[15]  N. Nowotny,et al.  Viraemia and abortions are not prevented by two commercial equine herpesvirus-1 vaccines after experimental challenge of horses. , 1990, The Veterinary quarterly.

[16]  J. Goust Cell-mediated immunity. , 1990, Immunology series.

[17]  D. Goodridge,et al.  Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 1 virus , 1984, Veterinary Record.

[18]  Scott Jc,et al.  In vivo harboring of equine herpesvirus-1 in leukocyte populations and subpopulations and their quantitation from experimentally infected ponies. , 1983 .

[19]  S. Dutta,et al.  In vivo harboring of equine herpesvirus-1 in leukocyte populations and subpopulations and their quantitation from experimentally infected ponies. , 1983, American Journal of Veterinary Research.